Related Experiment Video
Updated: Jun 10, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Cytotoxicity Induced by Bismuth Subcitrate in Giardia lamblia Trophozoites
M C Sousa1, J Poiares-da-Silva
1Laboratório de Microbiologia e Parasitologia and Centro de Estudos Farmacêuticos da Faculdade de Farmácia, Universidade de Coimbra, 3030 Coimbra, Portugal.
Abstract:
The cytotoxicity of colloidal bismuth subcitrate (CBS) was investigated in cultured Giardia lamblia trophozoites on the basis of cell attachment, morphology and viability studies. The effects on cell membrane integrity were evaluated by the permeability to trypan blue, and the morphological alterations were studied by phase-contrast microscopy and transmission electron microscopy. Our data show that although CBS induced loss of cellular viability (morphological and regrowth studies), the cell membrane permeability was not altered. The attachment of G. lamblia trophozoites to culture vials was rapidly disrupted by CBS. Ultrastructural observations revealed that this drug promoted modifications on the cell shape, displacement of nucleus and of cytoskeletal structures, pronounced cytoplasmic vacuolization, dorsal and ventral protuberance of cytoplasmic membrane and heavy deposition of electron-dense precipitates in adhesive disc, nuclear membrane and cytoplasmic components. In contrast, membranes and microtubules were apparently undamaged. Some of these results suggest that the cytotoxicity of CBS to G. lamblia cultures is the result of its binding to cytoskeletal components. As far as we know, this work is the first demonstration that bismuth subcitrate could kill a human protozoan parasite suggesting its potential in the therapy of giardiasis.
More Related Videos
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Related Concept Videos
Giardiasis
Antiprotozoal Agents
Amebiasis
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Bacterial Gastroenteritis